Increasing aclarubicin dosage of the conventional CAG (low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor) regimen is more efficacious as a salvage therapy than CAG for relapsed/refractory acute myeloid leukemia

Qi Qu(Xiamen University), Depei Wu(Zhejiang Chinese Medical University), Limin Liu(Soochow University), Xiaoli Li(Fujian Medical University), Yanming Zhang(Xuzhou Medical College)
Leukemia Research
September 19, 2015
Cited by 12


Related Papers